首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1678796

日本遠端病患監控市場 - 2025 至 2033 年

Japan Remote Patient Monitoring Market - 2025-2033

出版日期: 2025年03月11日 | 出版商:

DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本遠距病人監護市場規模達到 4.7056 億美元，預計到 2033 年將達到 35.3654 億美元，2025-2033 年預測期內的複合年成長率為 24.9%。

遠端病人監控 (RPM) 是一種醫療保健實踐，它使用數位技術從傳統環境之外的患者收集醫療資料，使醫生能夠即時或定期追蹤生命徵象。此技術對於患有慢性病的患者、老年人或術後照護者特別有益，因為它可以及時介入並減少就診次數。 RPM 允許在患者未實際身處醫療機構的情況下進行持續監測，從而加強了對患者的護理，改善了健康狀況，並提高了便利性。

市場動態：

促進因素與約束因素

科技進步和穿戴式裝置的普及

日本遠距病人監控 (RPM) 市場受到醫療技術進步和穿戴式醫療設備的日益普及的推動。這些設備追蹤即時健康參數，提高準確性和效率。它們與智慧型手機應用程式和雲端平台相結合，促進主動的患者管理。這項技術進步提高了患者的接受度，並鼓勵醫療保健提供者將 RPM 納入他們的實踐中。一般來說，老年人或慢性病患者是遠距病人監護設備的目標族群；然而，在日本，一些公司正在提出創新技術來追蹤各類患者的健康狀況。

例如，日本公司MEDIROM Healthcare technologies Inc.最近推出了創新產品“MOTHER Bracelet”，該產品是一款免充電的智慧健康追蹤器，可與遠端健康監測系統REMONY整合，從而廣受歡迎。 2025年1月，該公司與TOPPAN Inc.的電子部門合作，提供這些先進的監控設備。 TOPPAN計劃利用這些設備（MOTHER Bracelet和REMONY）來監測員工的健康狀況，並旨在建立一個能夠在出現某些健康異常時儘早發現並迅速應對的環境。

資料隱私和安全問題

由於對資料隱私和安全的擔憂，日本遠端病人監控 (RPM) 市場面臨重大挑戰。 RPM 系統收集和傳輸敏感的患者健康資料，任何違規都可能導致未經授權的存取。嚴格的資料保護法規和對安全漏洞的擔憂阻礙了患者和醫療保健提供者全面採用 RPM 解決方案，從而阻礙了市場成長。

Remote Patient Monitoring (RPM) is a healthcare practice that uses digital technologies to collect medical data from patients outside traditional settings, enabling doctors to track vital signs in real time or periodically. This technology is particularly beneficial for patients with chronic conditions, elderly individuals, or post-operative care, as it allows timely interventions and reduces hospital visits. RPM enhances patient care, improves health outcomes, and promotes convenience by allowing continuous monitoring without physically present patients in a healthcare facility.

Market Dynamics: Drivers & Restraints

Technological Advancements and Increasing Adoption of Wearable Devices

The Japan remote patient monitoring (RPM) market is driven by advancements in healthcare technology and the growing use of wearable health devices. These devices track real-time health parameters, improving accuracy and efficiency. They are integrated with smartphone applications and cloud platforms, promoting proactive patient management. This technological evolution has increased patient acceptance and encouraged healthcare providers to incorporate RPM into their practices. Generally, elderly or chronic disease patients are the target population for remote patient monitoring devices; however, in Japan, several companies are coming up with innovations to track the health and wellness of all types of patients.

For instance, a Japan-based company, MEDIROM Healthcare technologies Inc., has recently become popular with the launch of its innovation, the "MOTHER Bracelet", a charging-free smart health tracker that is integrated with REMONY, a remote health monitoring system. In January 2025, the company collaborated with the Electronics Division of TOPPAN Inc. to provide these advanced monitoring devices. TOPPAN plans to use these devices, the MOTHER Bracelet and REMONY, for the health monitoring of its employees and aims to establish an environment that enables early detection and prompt responses in the event of certain health abnormalities.

Data Privacy and Security Concerns

The Japanese remote patient monitoring (RPM) market faces significant challenges due to concerns over data privacy and security. RPM systems collect and transmit sensitive patient health data, and any breach can lead to unauthorized access. Strict data protection regulations and fear of security vulnerabilities discourage patients and healthcare providers from fully adopting RPM solutions, hindering market growth.

Segment Analysis

The Japan remote patient monitoring market is segmented based on device type, application, and end user.

Device Type:

Wearable Devices in the device type segment are expected to dominate with the highest market share.

Japan's remote patient monitoring (RPM) market is thriving due to wearable devices that enable real-time health tracking, early disease detection, and continuous management of chronic conditions. These devices collect vital health data, such as heart rate, blood pressure, oxygen levels, and glucose levels. The integration of AI and IoT in wearable technology improves data analysis, reduces hospital visits, and enhances patient engagement, particularly in Japan's aging population and increasing demand for home-based care. Several innovative wearable devices are being launched in the Japanese market, which can significantly tap the areas with high unmet needs.

For instance, in September 2024, iRhythm Technologies, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency (PMDA) has approved Zio fourteen-day, long-term continuous ECG monitoring system. Zio is a wearable device supported with ZEUS - Zio ECG Utilization Software System and iRhythm's advanced AI algorithm, and can be used in the early diagnosis of cardiac arrhythmias.

Competitive Landscape

The major country players in the remote patient monitoring market include Nihon Kohden Corporation, OMRON Healthcare Co., Ltd Terumo Corporation, Fukuda Denshi Co., Ltd, Panasonic Healthcare Co., Ltd., Sharp Corporation (Healthcare Devices Division), Medirom Healthcare Technologies Inc, A&D Company, Limited, HealthNode, Medical Edge Co Ltd and among others.

Key Developments

In April 2024, OMRON Healthcare Co., Ltd. acquired Luscii Healthtech, a rapidly growing digital health and remote consultation service platform. Since OMRON's seed investment in 2018, the two companies have collaborated on digital health development. Luscii, a pioneer in smart remote care and virtual wards, has a unique culture for innovation and an agile philosophy, enabling them to address the complex demands of healthcare systems.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Country's Growth & Investment: Highlights high-growth countries and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Remote Patient Monitoring market report delivers a detailed analysis with 72 key tables, more than 67 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Country

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements and Increasing Adoption of Wearable Devices
- 4.1.2. Restraints
  - 4.1.2.1. Data Privacy and Security Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Device Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 6.1.2. Market Attractiveness Index, By Device Type
6.2. Wearable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Wearable Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Chronic Disease Management*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Post-Operative Care
7.4. Maternal Health
7.5. Mental Health
7.6. Emergency Care
7.7. General Health and Wellness
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare Settings
8.4. Others

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

10.1. Nihon Kohden Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
10.2. OMRON Healthcare Co., Ltd.
10.3. Terumo Corporation
10.4. Fukuda Denshi Co., Ltd.
10.5. Panasonic Healthcare Co., Ltd.
10.6. Sharp Corporation (Healthcare Devices Division)
10.7. Medirom Healthcare Technologies Inc
10.8. A&D Company, Limited
10.9. HealthNode
10.10. Medical Edge Co Ltd
Similar data will be provided for each market player.